佛罗里达州COVID-19专科病房耳念珠菌暴发
2020年7月,佛罗里达州一家急性期护理医院(医院A)的COVID-19专病单元中,4名COVID-19患者出现3例耳念珠菌血流感染和1例尿路感染。耳念珠菌为多重耐药酵母菌,可无症状定植并污染环境,医院A在新冠疫情前曾实施入院筛查并将定植患者收治于独立病房。
要点
- COVID-19专病单元内出现耳念珠菌血流和尿路感染聚集。
- 耳念珠菌多重耐药、可无症状定植并持续污染环境。
- 疫情前医院A常规开展耳念珠菌入院筛查及定植患者分区收治。
核心结论
- 2020年7—8月佛罗里达州医院A的COVID-19专病单元发生耳念珠菌感染聚集,涉及4名患者的血流和尿路感染。
研究设计与样本
- 基于佛罗里达州卫生部门2020年7月接报的4例COVID-19患者耳念珠菌感染进行的暴发调查描述。
主要发现
- 4名COVID-19患者中发生3例耳念珠菌血流感染和1例尿路感染。
- 耳念珠菌为多重耐药酵母菌,可无症状定植于患者并持续存活于物体表面。
临床怎么用
- COVID-19专病单元应警惕耳念珠菌感染聚集,并关注无症状定植和环境持续污染。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In July 2020, the Florida Department of Health was alerted to three Candida auris bloodstream infections and one urinary tract infection in four patients with coronavirus disease 2019 (COVID-19) who received care in the same dedicated COVID-19 unit of an acute care hospital (hospital A). C. auris is a multidrug-resistant yeast that can cause invasive infection. Its ability to colonize patients asymptomatically and persist on surfaces has contributed to previous C. auris outbreaks in health care settings (1-7). Since the first C. auris case was identified in Florida in 2017, aggressive measures have been implemented to limit spread, including contact tracing and screening upon detection of a new case. Before the COVID-19 pandemic, hospital A conducted admission screening for C. auris and admitted colonized patients to a separate dedicated ward.
引用
- Prestel C, Anderson E, Forsberg K, et al. Candida auris Outbreak in a COVID-19 Specialty Care Unit - Florida, July-August 2020. MMWR Morb Mortal Wkly Rep. 2021. PMID: 33444298. doi:10.15585/mmwr.mm7002e3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。